Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes. / Snorgaard, Ole; Møller, Grith; Andersen, Henning K; Astrup, Arne.

In: B M J Open Diabetes Research & Care, Vol. 5, e000354, 2017.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Snorgaard, O, Møller, G, Andersen, HK & Astrup, A 2017, 'Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes', B M J Open Diabetes Research & Care, vol. 5, e000354. https://doi.org/10.1136/bmjdrc-2016-000354

APA

Snorgaard, O., Møller, G., Andersen, H. K., & Astrup, A. (2017). Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes. B M J Open Diabetes Research & Care, 5, [e000354]. https://doi.org/10.1136/bmjdrc-2016-000354

Vancouver

Snorgaard O, Møller G, Andersen HK, Astrup A. Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes. B M J Open Diabetes Research & Care. 2017;5. e000354. https://doi.org/10.1136/bmjdrc-2016-000354

Author

Snorgaard, Ole ; Møller, Grith ; Andersen, Henning K ; Astrup, Arne. / Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes. In: B M J Open Diabetes Research & Care. 2017 ; Vol. 5.

Bibtex

@article{bb1d95504ea2466ab2c5f71c69efd705,
title = "Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes",
abstract = "Objective: Nutrition therapy is an integral part of selfmanagement education in patients with type 2 diabetes. Carbohydrates with a low glycemic index arerecommended, but the ideal amount of carbohydrate in the diet is unclear. We performed a meta-analysis comparing diets containing low to moderate amountsof carbohydrate (LCD) (energy percentage below 45{\%}) to diets containing high amounts of carbohydrate (HCD) in subjects with type 2 diabetes.Research design and methods: We systematically reviewed Cochrane library databases, EMBASE, and MEDLINE in the period 2004–2014 for guidelines,meta-analyses, and randomized trials assessing the outcomes HbA1c, BMI, weight, LDL cholesterol, quality of life (QoL), and attrition.Results: We identified 10 randomized trials comprising 1376 participants in total. In the first year of intervention, LCD was followed by a 0.34{\%} lower HbA1c (3.7 mmol/mol) compared with HCD (95{\%} CI 0.06 (0.7 mmol/mol), 0.63 (6.9 mmol/mol)). The greater the carbohydrate restriction, the greater theglucose-lowering effect (R=−0.85, p<0.01). At 1 year or later, however, HbA1c was similar in the 2 diet groups. The effect of the 2 types of diet on BMI/bodyweight, LDL cholesterol, QoL, and attrition rate was similar throughout interventions.Limitations: Glucose-lowering medication, the nutrition therapy, the amount of carbohydrate in the diet, glycemic index, fat and protein intake, baseline HbA1c, and adherence to the prescribed diets could all have affected the outcomes.Conclusions: Low to moderate carbohydrate diets have greater effect on glycemic control in type 2 diabetes compared with high-carbohydrate diets in the first year of intervention. The greater the carbohydrate restriction, the greater glucose lowering, a relationship that has not been demonstrated earlier. Apart from thislowering of HbA1c over the short term, there is no superiority of low-carbohydrate diets in terms of glycemic control, weight, or LDL cholesterol.",
author = "Ole Snorgaard and Grith M{\o}ller and Andersen, {Henning K} and Arne Astrup",
note = "CURIS 2017 NEXS 070",
year = "2017",
doi = "10.1136/bmjdrc-2016-000354",
language = "English",
volume = "5",
journal = "B M J Open Diabetes Research & Care",
issn = "2052-4897",
publisher = "B M J Group",

}

RIS

TY - JOUR

T1 - Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes

AU - Snorgaard, Ole

AU - Møller, Grith

AU - Andersen, Henning K

AU - Astrup, Arne

N1 - CURIS 2017 NEXS 070

PY - 2017

Y1 - 2017

N2 - Objective: Nutrition therapy is an integral part of selfmanagement education in patients with type 2 diabetes. Carbohydrates with a low glycemic index arerecommended, but the ideal amount of carbohydrate in the diet is unclear. We performed a meta-analysis comparing diets containing low to moderate amountsof carbohydrate (LCD) (energy percentage below 45%) to diets containing high amounts of carbohydrate (HCD) in subjects with type 2 diabetes.Research design and methods: We systematically reviewed Cochrane library databases, EMBASE, and MEDLINE in the period 2004–2014 for guidelines,meta-analyses, and randomized trials assessing the outcomes HbA1c, BMI, weight, LDL cholesterol, quality of life (QoL), and attrition.Results: We identified 10 randomized trials comprising 1376 participants in total. In the first year of intervention, LCD was followed by a 0.34% lower HbA1c (3.7 mmol/mol) compared with HCD (95% CI 0.06 (0.7 mmol/mol), 0.63 (6.9 mmol/mol)). The greater the carbohydrate restriction, the greater theglucose-lowering effect (R=−0.85, p<0.01). At 1 year or later, however, HbA1c was similar in the 2 diet groups. The effect of the 2 types of diet on BMI/bodyweight, LDL cholesterol, QoL, and attrition rate was similar throughout interventions.Limitations: Glucose-lowering medication, the nutrition therapy, the amount of carbohydrate in the diet, glycemic index, fat and protein intake, baseline HbA1c, and adherence to the prescribed diets could all have affected the outcomes.Conclusions: Low to moderate carbohydrate diets have greater effect on glycemic control in type 2 diabetes compared with high-carbohydrate diets in the first year of intervention. The greater the carbohydrate restriction, the greater glucose lowering, a relationship that has not been demonstrated earlier. Apart from thislowering of HbA1c over the short term, there is no superiority of low-carbohydrate diets in terms of glycemic control, weight, or LDL cholesterol.

AB - Objective: Nutrition therapy is an integral part of selfmanagement education in patients with type 2 diabetes. Carbohydrates with a low glycemic index arerecommended, but the ideal amount of carbohydrate in the diet is unclear. We performed a meta-analysis comparing diets containing low to moderate amountsof carbohydrate (LCD) (energy percentage below 45%) to diets containing high amounts of carbohydrate (HCD) in subjects with type 2 diabetes.Research design and methods: We systematically reviewed Cochrane library databases, EMBASE, and MEDLINE in the period 2004–2014 for guidelines,meta-analyses, and randomized trials assessing the outcomes HbA1c, BMI, weight, LDL cholesterol, quality of life (QoL), and attrition.Results: We identified 10 randomized trials comprising 1376 participants in total. In the first year of intervention, LCD was followed by a 0.34% lower HbA1c (3.7 mmol/mol) compared with HCD (95% CI 0.06 (0.7 mmol/mol), 0.63 (6.9 mmol/mol)). The greater the carbohydrate restriction, the greater theglucose-lowering effect (R=−0.85, p<0.01). At 1 year or later, however, HbA1c was similar in the 2 diet groups. The effect of the 2 types of diet on BMI/bodyweight, LDL cholesterol, QoL, and attrition rate was similar throughout interventions.Limitations: Glucose-lowering medication, the nutrition therapy, the amount of carbohydrate in the diet, glycemic index, fat and protein intake, baseline HbA1c, and adherence to the prescribed diets could all have affected the outcomes.Conclusions: Low to moderate carbohydrate diets have greater effect on glycemic control in type 2 diabetes compared with high-carbohydrate diets in the first year of intervention. The greater the carbohydrate restriction, the greater glucose lowering, a relationship that has not been demonstrated earlier. Apart from thislowering of HbA1c over the short term, there is no superiority of low-carbohydrate diets in terms of glycemic control, weight, or LDL cholesterol.

U2 - 10.1136/bmjdrc-2016-000354

DO - 10.1136/bmjdrc-2016-000354

M3 - Journal article

C2 - 28316796

VL - 5

JO - B M J Open Diabetes Research & Care

JF - B M J Open Diabetes Research & Care

SN - 2052-4897

M1 - e000354

ER -

ID: 173938419